Knowledge mapping of immunotherapy for thyroid cancer from 1980 to 2022: A review.
Journal
Medicine
ISSN: 1536-5964
Titre abrégé: Medicine (Baltimore)
Pays: United States
ID NLM: 2985248R
Informations de publication
Date de publication:
29 Sep 2023
29 Sep 2023
Historique:
medline:
5
10
2023
pubmed:
29
9
2023
entrez:
29
9
2023
Statut:
ppublish
Résumé
With the gradual development of immunotherapy for thyroid cancer, relevant research has increased. To better understand the current situation, development trend, evolution process, and research hotspots of this field, we conducted this comprehensive bibliometrics visual analysis. We retrieved papers published from 1980 to 2022 from Web of Science Core Collection on January 31, 2023. CiteSpace, Pajek, VOSviewer, R-Bibliometrix, and Scimago Graphics are the tools to perform the analysis. Analysis methods mainly include co-occurrence analysis and cluster analysis. Analysis objects are countries or regions, institutions, authors, journals, and keywords, etc. In terms of publication number, the recent decade has witnessed rapid growth. USA was the most prolific country and has the most influence in the cooperation team. Sweden took the lead in focus on this research field and lasted for 21 years. Garden State Cancer Center was released most papers (28). INSERM played a major role in institutional cooperation. Goldenberg DM published the most papers (48), with H-Index 25 and G-Index 43. Journal of Nuclear Medicine has the greatest papers published (41). The average impactor factor of the top 10 journals is 7.2058. The top keywords with high burst strength are: radioimmunotherapy (14.85), monoclonal antibody (13.78), non hodgkins lymphoma (12.54). The research field of immunotherapy for thyroid cancer will be further developed. This study provides a valuable reference for future research in the field.
Identifiants
pubmed: 37773801
doi: 10.1097/MD.0000000000035506
pii: 00005792-202309290-00019
pmc: PMC10545358
doi:
Substances chimiques
Antibodies, Monoclonal
0
Types de publication
Review
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e35506Informations de copyright
Copyright © 2023 the Author(s). Published by Wolters Kluwer Health, Inc.
Déclaration de conflit d'intérêts
The authors have no funding and conflicts of interest to disclose.
Références
Cancer Res Treat. 2022 Apr;54(2):330-344
pubmed: 35313102
Ann Oncol. 2022 Apr;33(4):406-415
pubmed: 35026411
Front Immunol. 2022 Nov 01;13:995645
pubmed: 36389678
J Formos Med Assoc. 2022 Jun;121(6):1167-1173
pubmed: 35031200
Front Oncol. 2022 Aug 30;12:947658
pubmed: 36110958
Curr Pharm Des. 2022;28(29):2387-2403
pubmed: 35909273
Q J Nucl Med Mol Imaging. 2021 Jun;65(2):138-156
pubmed: 33565845
Ther Adv Endocrinol Metab. 2022 Apr 17;13:20420188221090012
pubmed: 35464880
J Transl Med. 2022 Feb 11;20(1):83
pubmed: 35148757
Front Microbiol. 2014 May 20;5:219
pubmed: 24904535
J Clin Endocrinol Metab. 2013 Apr;98(4):1361-75
pubmed: 23471977
Nat Rev Endocrinol. 2017 Apr;13(4):195-207
pubmed: 28106152
N Engl J Med. 1974 Jan 24;290(4):193-7
pubmed: 4808917
Front Immunol. 2022 Oct 27;13:1014981
pubmed: 36389756
Acta Pharm Sin B. 2022 Aug;12(8):3233-3254
pubmed: 35967284
Front Immunol. 2022 Sep 08;13:991656
pubmed: 36211409
Semin Cancer Biol. 2018 Oct;52(Pt 1):103-109
pubmed: 29183778
Scientometrics. 2017;111(2):1053-1070
pubmed: 28490825
Surgery. 1983 Dec;94(6):959-65
pubmed: 6648811
Lancet Oncol. 2020 Oct;21(10):1353-1365
pubmed: 32919526
PLoS One. 2016 Jul 29;11(7):e0160221
pubmed: 27472273
Nat Rev Cancer. 2013 Mar;13(3):184-99
pubmed: 23429735
Cancers (Basel). 2022 Jul 10;14(14):
pubmed: 35884418
CA Cancer J Clin. 2022 Jan;72(1):7-33
pubmed: 35020204
Nat Commun. 2022 Mar 24;13(1):1588
pubmed: 35332119
Nat Rev Clin Oncol. 2016 Aug;13(8):473-86
pubmed: 27141885
Front Immunol. 2022 Dec 13;13:1048503
pubmed: 36582246
JAMA Otolaryngol Head Neck Surg. 2014 Apr;140(4):317-22
pubmed: 24557566
Arch Intern Med. 1994 Aug 22;154(16):1838-40
pubmed: 8053752
Life (Basel). 2023 Jun 15;13(6):
pubmed: 37374179
Thyroid. 2021 Jul;31(7):1076-1085
pubmed: 33509020
Front Immunol. 2022 Aug 24;13:952546
pubmed: 36090978
Am J Pharm Educ. 2009 Oct 1;73(6):111
pubmed: 19885080
Mol Cell Endocrinol. 2022 Feb 5;541:111491
pubmed: 34740746
Immunol Allergy Clin North Am. 2022 Feb;42(1):105-119
pubmed: 34823741
J Endocrinol Invest. 2019 Mar;42(3):261-270
pubmed: 29872995
J Allergy Clin Immunol. 2020 Dec;146(6):1286-1287
pubmed: 33280713
Front Oncol. 2022 Mar 01;12:843735
pubmed: 35299747
Front Oncol. 2022 Nov 09;12:978608
pubmed: 36439496
Cancer Cell Int. 2022 Oct 10;22(1):307
pubmed: 36217201
Scientometrics. 2010 Aug;84(2):523-538
pubmed: 20585380
J Mater Chem B. 2022 Sep 28;10(37):7183-7193
pubmed: 35348177
Sci Total Environ. 2020 Apr 20;714:136776
pubmed: 31991269
JAMA Surg. 2020 Nov 1;155(11):1080-1081
pubmed: 32936239
Nat Rev Endocrinol. 2021 Jul;17(7):389-399
pubmed: 33875857
Endocrine. 2023 May;80(2):355-365
pubmed: 36607509
Endocrinol Metab Clin North Am. 2019 Mar;48(1):23-35
pubmed: 30717905
Bioimpacts. 2022;12(3):261-290
pubmed: 35677663
Eur J Med Chem. 2023 Jan 5;245(Pt 2):114920
pubmed: 36399875
Lancet Diabetes Endocrinol. 2021 Mar;9(3):144-152
pubmed: 33482107
Ann Oncol. 2019 Dec 1;30(12):1856-1883
pubmed: 31549998
Proc Natl Acad Sci U S A. 2004 Apr 6;101 Suppl 1:5303-10
pubmed: 14724295
World J Surg. 2019 Apr;43(4):967-972
pubmed: 30564922
Front Oncol. 2022 Jan 31;12:678025
pubmed: 35174076
Int J Mol Sci. 2022 May 20;23(10):
pubmed: 35628540
Cancer Manag Res. 2020 Jul 06;12:5431-5438
pubmed: 32753960
Front Immunol. 2022 Oct 27;13:1013049
pubmed: 36389799
Front Oncol. 2021 Jan 25;10:592202
pubmed: 33569345
Ann Oncol. 2019 Aug 1;30(8):1279-1288
pubmed: 31095287
CA Cancer J Clin. 2022 Sep;72(5):409-436
pubmed: 35736631
Pharmaceutics. 2022 Aug 04;14(8):
pubmed: 36015256
Blood. 2000 Aug 15;96(4):1259-66
pubmed: 10942366
Front Pharmacol. 2022 Sep 14;13:940791
pubmed: 36188597
Brain. 2005 Aug;128(Pt 8):1764-77
pubmed: 15888538
Biosensors (Basel). 2022 Aug 08;12(8):
pubmed: 36005013
Ann Pediatr Endocrinol Metab. 2021 Mar;26(1):53-59
pubmed: 33819958
Environ Res. 2021 Nov;202:111694
pubmed: 34274334
J Clin Oncol. 2006 Feb 10;24(5):823-34
pubmed: 16380412
Eur Arch Otorhinolaryngol. 2016 Jun;273(6):1347-55
pubmed: 25673026